TSHA

TAYSHA GENE THERAPIES INC

TSHA·877619106·US·Common Stock·Healthcare - Biotechnology-Activist

TSHA (TAYSHA GENE THERAPIES INC) is held by 117 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($105.3M), GOLDMAN SACHS GROUP INC ($100M), Avoro Capital Advisors LLC ($97M). Net institutional sentiment: Mixed.

117
Holders
Avg rating(26 Elite)
$920.1M
Total Value
55% (130)
Fund Consensus
60 buying - 50 selling
TSHASmart Money Verdict
View all
Held by 117 funds
26 elite
Who's Trading
InsiderNSNagendran SukumarSell $1.2MJul 10, 2026
ActivistRTW Investments, LPRTW Investments, LP7.0%May 15, 2026
ActivistVPVestal Point Capital, LP6.3%May 15, 2026
InsiderNSNagendran SukumarSell $892KApr 10, 2026
ActivistFMR LLCFMR LLC4.9%Feb 5, 2026
InsiderNPNolan Sean P.Sell $190KJan 26, 2026
InsiderAKAlam KamranSell $110KJan 26, 2026
InsiderNSNagendran SukumarSell $124KJan 26, 2026
InsiderNPNolan Sean P.Sell $650KJan 23, 2026
InsiderAKAlam KamranSell $375KJan 23, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
23.6M$105.3M1.1%+131.39%
0
Increased
22.4M(+63.4%)$100M0.0%+93.49%
44
Unchanged
21.7M$97M1.0%+127.13%
0
Decreased
18.4M(-1.5%)$82.1M0.0%+159.23%
0
Decreased
18M(-0.6%)$80.3M0.0%+201.43%
0
Increased
14.3M(+5.9%)$64M0.0%+236.34%
31
Decreased
13.7M(-16.6%)$61.2M0.6%+158.16%
0
Increased
11.2M(+3.9%)$50.1M0.0%+79.15%
30
New
10.2M$45.7M0.0%+39.96%
40
Decreased
5.7M(-28.7%)$25.3M0.1%+69.68%
0
Increased
5.5M(+2.7%)$24.7M0.0%+85.21%
29
Increased
4.4M(+10.3%)$19.8M0.0%+60.29%
31
Unchanged
4M$17.9M0.1%+140.21%
0
Increased
3.3M(+3.2%)$14.7M0.0%+158.47%
29
Decreased
2.9M(-22.5%)$12.9M0.0%+12.01%
0
Decreased
2.8M(-49.2%)$11.4M0.0%+95.72%
0
New
2M$9M0.0%+39.96%
38
Increased
1.8M(+46.5%)$8.1M0.0%+92.95%
37
Decreased
1.8M(-5.0%)$8.1M0.0%+101.75%
0
Increased
1.7M(+45.5%)$7.5M0.0%+106.44%
37

Showing 1-20 of 130

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used